Longaeva Partners »

Evommune shares owned by Longaeva Partners

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 117k 13.29

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Jpmorgan Chase & Co
Rtw Investments
Nan Fung Group Holdings
Point72 Asset Management
Andera Partners
SymBiosis Capital Partners
Eventide Asset Management
T. Rowe Price Associates
Vestal Point Capital
Henderson Group
Jupiter Topco
BlackRock

View all funds holding Evommune